ECAM is waiting for eCAM.

Chinese Herbal Medicine for Dysfunctional Uterine Bleeding: a Meta-analysis. Evid Based Complement Alternat Med (2007) 0.78

eCAM: Early Harvest. Evid Based Complement Alternat Med (2008) 0.75

Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol (1989) 12.08

Traditional and Modern Biomedical Prospecting: Part II-the Benefits: Approaches for a Sustainable Exploitation of Biodiversity (Secondary Metabolites and Biomaterials from Sponges). Evid Based Complement Alternat Med (2004) 2.53

CAM Modalities Can Stimulate Advances in Theoretical Biology. Evid Based Complement Alternat Med (2005) 2.19

Digging for innate immunity since Darwin and Metchnikoff. Bioessays (2002) 2.13

Bioprospecting: a CAM Frontier. Evid Based Complement Alternat Med (2005) 1.82

Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: "waiting for Godot". Immunogenetics (2003) 1.75

Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found Symp (1994) 1.58

Complementary and alternative medicine: assessing the evidence for immunological benefits. Nat Rev Immunol (2004) 1.43

CAM and cell fate targeting: molecular and energetic insights into cell growth and differentiation. Evid Based Complement Alternat Med (2005) 1.35

The systemic theory of living systems and relevance to CAM: the theory (Part III). Evid Based Complement Alternat Med (2005) 1.25

Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling. Evid Based Complement Alternat Med (2004) 1.24

IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR). Evid Based Complement Alternat Med (2004) 1.03

Anticipating innate immunity without a Toll. Mol Immunol (2004) 0.87

CAM, eCAM, Bioprospecting: The 21st Century Pyramid. Evid Based Complement Alternat Med (2005) 2.68

Drug Discovery, CAM and Natural Products. Evid Based Complement Alternat Med (2004) 2.64

Bioprospecting: a CAM Frontier. Evid Based Complement Alternat Med (2005) 1.82

Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med (2011) 1.49

The danger theory: 20 years later. Front Immunol (2012) 1.38

Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A (2005) 1.35

Commentary on Traditional and Modern Biomedical Prospecting: Part II-The Benefits by Werner E.G. Muller, Heinz C. Schroder, Matthias Wiens, Sanja Perovic-Ottstadt, Renato Batel and Isabel M. Muller: Anti-protozoa and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard. Evid Based Complement Alternat Med (2004) 1.14

Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res (2005) 1.07

Regional Strength in CAM. Evid Based Complement Alternat Med (2006) 1.04

Sex-specific effects of carotenoid intake on the immunological response to allografts in guppies (Poecilia reticulata). Proc Biol Sci (2004) 1.00

Nervous, endocrine, immune systems as a target for complementary and alternative medicine. Adv Exp Med Biol (2004) 0.92

Hypothetical mode of action of earthworm extract with hepatoprotective and antioxidant properties. J Zhejiang Univ Sci B (2008) 0.89

eCAM: On To Year 4. Evid Based Complement Alternat Med (2006) 0.87

Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. Leuk Res (2008) 0.87

Is there room for paradox in CAM? Evid Based Complement Alternat Med (2007) 0.86

Toll-like receptor genes (TLRs) from Capitella capitata and Helobdella robusta (Annelida). Dev Comp Immunol (2007) 0.86

Stem cells and CAM. Evid Based Complement Alternat Med (2006) 0.85

Evaluation of an innate immune reaction to parasites in earthworms. J Invertebr Pathol (2004) 0.84

Leech responses to tissue transplantation. Tissue Cell (2003) 0.82

Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol (2004) 0.80

Monoclonal antibodies identify four distinct annelid leukocyte markers. Dev Comp Immunol (2004) 0.80

Mass spectrometric analyses of CL(39), CL(41) and H(1), H(2), H(3) confirm identity with fetidin and lysenin produced by earthworm leukocytes. Dev Comp Immunol (2003) 0.79

Leeches: immune response, angiogenesis and biomedical applications. Curr Pharm Des (2003) 0.78

eCAM: moving forward. Evid Based Complement Alternat Med (2007) 0.78

eCAM: Darwin and Metchnikoff. Evid Based Complement Alternat Med (2009) 0.78

Earthworm leukocytes react with different mammalian antigen-specific monoclonal antibodies. Zoology (Jena) (2002) 0.77

eCAM: Clinical Analyses and Increasing Visibility. Evid Based Complement Alternat Med (2009) 0.77

Immune systems, geographic information systems (GIS), environment and health impacts. J Toxicol Environ Health B Crit Rev (2004) 0.77

Coelomocyte locomotion in the sipunculan Themiste petricola induced by exogenous and endogenous chemoattractants: role of a CD44-like antigen--HA interaction. J Invertebr Pathol (2002) 0.77

eCAM benefits from diversity that derives from CAM. Evid Based Complement Alternat Med (2005) 0.77

Colony collapse disorder may affect complementary and alternative medicine. Evid Based Complement Alternat Med (2007) 0.75

Marine biotechnology. Evid Based Complement Alternat Med (2011) 0.75

Neuroendocrine mechanisms of acupuncture. Evid Based Complement Alternat Med (2012) 0.75

Identification of diseases that may be targets for complementary and alternative medicine (CAM). Adv Exp Med Biol (2004) 0.75

Brian Solomon. Dev Comp Immunol (2015) 0.75

Pomegranate: its health and biomedical potential. Evid Based Complement Alternat Med (2013) 0.75

Medical ethnobiology and ethnopharmacology in latin america. Evid Based Complement Alternat Med (2012) 0.75